161 related articles for article (PubMed ID: 33894488)
21. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
[TBL] [Abstract][Full Text] [Related]
22. Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors.
Sciaraffia E; Riccomi A; Lindstedt R; Gesa V; Cirelli E; Patrizio M; De Magistris MT; Vendetti S
J Leukoc Biol; 2014 Jul; 96(1):113-22. PubMed ID: 24652540
[TBL] [Abstract][Full Text] [Related]
23. Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors.
Conde SV; Obeso A; Vicario I; Rigual R; Rocher A; Gonzalez C
J Neurochem; 2006 Jul; 98(2):616-28. PubMed ID: 16805851
[TBL] [Abstract][Full Text] [Related]
24. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.
Dickenson JM; Reeder S; Rees B; Alexander S; Kendall D
Eur J Pharmacol; 2003 Aug; 474(1):43-51. PubMed ID: 12909194
[TBL] [Abstract][Full Text] [Related]
25. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
26. PSB 603 - a known selective adenosine A2B receptor antagonist - has anti-inflammatory activity in mice.
Kotańska M; Szafarz M; Mika K; Dziubina A; Bednarski M; Müller CE; Sapa J; Kieć-Kononowicz K
Biomed Pharmacother; 2021 Mar; 135():111164. PubMed ID: 33385856
[TBL] [Abstract][Full Text] [Related]
27. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.
Xi J; McIntosh R; Shen X; Lee S; Chanoit G; Criswell H; Zvara DA; Xu Z
J Mol Cell Cardiol; 2009 Nov; 47(5):684-90. PubMed ID: 19695259
[TBL] [Abstract][Full Text] [Related]
28. A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models.
Willingham SB; Ho PY; Hotson A; Hill C; Piccione EC; Hsieh J; Liu L; Buggy JJ; McCaffery I; Miller RA
Cancer Immunol Res; 2018 Oct; 6(10):1136-1149. PubMed ID: 30131376
[TBL] [Abstract][Full Text] [Related]
29. New 8-substituted xanthiene derivatives as potent bronchodilators.
Berk B; Akgün H; Erol K; Sirmagül B; Gao ZG; Jacobson KA
Farmaco; 2005; 60(11-12):974-80. PubMed ID: 16243321
[TBL] [Abstract][Full Text] [Related]
30. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
31. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
32. Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).
Stasi MA; Minetti P; Lombardo K; Riccioni T; Caprioli A; Vertechy M; Di Serio S; Pace S; Borsini F
Eur J Pharmacol; 2015 Aug; 761():353-61. PubMed ID: 25936513
[TBL] [Abstract][Full Text] [Related]
33. Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.
Wolska N; Rozalski M
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684173
[TBL] [Abstract][Full Text] [Related]
34. Lipoteichoic acid from Staphylococcus aureus increases matrix metalloproteinase 9 expression in RAW 264.7 macrophages: modulation by A2A and A2B adenosine receptors.
Souza LF; Jardim FR; Sauter IP; Souza MM; Barreto F; Margis R; Bernard EA
Mol Immunol; 2009 Feb; 46(5):937-42. PubMed ID: 18950865
[TBL] [Abstract][Full Text] [Related]
35. Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway.
Ko IG; Jin JJ; Hwang L; Kim SH; Kim CJ; Jeon JW; Chung JY; Han JH
PLoS One; 2021; 16(3):e0248689. PubMed ID: 33735236
[TBL] [Abstract][Full Text] [Related]
36. Adenosine-stimulated adrenal steroidogenesis involves the adenosine A2A and A2B receptors and the Janus kinase 2-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase signaling pathway.
Chen YC; Huang SH; Wang SM
Int J Biochem Cell Biol; 2008; 40(12):2815-25. PubMed ID: 18582595
[TBL] [Abstract][Full Text] [Related]
37. Blockade of adenosine A2B receptors ameliorates murine colitis.
Kolachala V; Ruble B; Vijay-Kumar M; Wang L; Mwangi S; Figler H; Figler R; Srinivasan S; Gewirtz A; Linden J; Merlin D; Sitaraman S
Br J Pharmacol; 2008 Sep; 155(1):127-37. PubMed ID: 18536750
[TBL] [Abstract][Full Text] [Related]
38. Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
Evans JV; Suman S; Goruganthu MUL; Tchekneva EE; Guan S; Arasada RR; Antonucci A; Piao L; Ilgisonis I; Bobko AA; Driesschaert B; Uzhachenko RV; Hoyd R; Samouilov A; Amann J; Wu R; Wei L; Pallerla A; Ryzhov SV; Feoktistov I; Park KP; Kikuchi T; Castro J; Ivanova AV; Kanagasabai T; Owen DH; Spakowicz DJ; Zweier JL; Carbone DP; Novitskiy SV; Khramtsov VV; Shanker A; Dikov MM
J Natl Cancer Inst; 2023 Nov; 115(11):1404-1419. PubMed ID: 37195421
[TBL] [Abstract][Full Text] [Related]
39. A
De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
[TBL] [Abstract][Full Text] [Related]
40. Systematic deletion of adenosine receptors reveals novel roles in inflammation and pyroptosis in THP-1 macrophages.
Eudy BJ; da Silva RP
Mol Immunol; 2021 Apr; 132():1-7. PubMed ID: 33524770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
